57 related articles for article (PubMed ID: 38728446)
1. Identification of the new molecular subtypes related to inflammation in breast cancer.
Yu K; Xu C; Wang F; Wang H
Medicine (Baltimore); 2024 May; 103(19):e38146. PubMed ID: 38728446
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment.
Habanjar O; Bingula R; Decombat C; Diab-Assaf M; Caldefie-Chezet F; Delort L
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835413
[TBL] [Abstract][Full Text] [Related]
3. EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer.
Wang X; Semba T; Manyam GC; Wang J; Shao S; Bertucci F; Finetti P; Krishnamurthy S; Phi LTH; Pearson T; Van Laere SJ; Burks JK; Cohen EN; Reuben JM; Yang F; Min H; Navin N; Trinh VN; Iwase T; Batra H; Shen Y; Zhang X; Tripathy D; Ueno NT
Sci Adv; 2022 Dec; 8(50):eabn7983. PubMed ID: 36525493
[TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicles from triple negative breast cancer promote pro-inflammatory macrophages associated with better clinical outcome.
Tkach M; Thalmensi J; Timperi E; Gueguen P; Névo N; Grisard E; Sirven P; Cocozza F; Gouronnec A; Martin-Jaular L; Jouve M; Delisle F; Manel N; Rookhuizen DC; Guerin CL; Soumelis V; Romano E; Segura E; Théry C
Proc Natl Acad Sci U S A; 2022 Apr; 119(17):e2107394119. PubMed ID: 35439048
[TBL] [Abstract][Full Text] [Related]
5. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data.
Maeser D; Gruener RF; Huang RS
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34260682
[TBL] [Abstract][Full Text] [Related]
6. Checkpoint inhibitor therapy for metastatic triple-negative breast cancer.
Heeke AL; Tan AR
Cancer Metastasis Rev; 2021 Jun; 40(2):537-547. PubMed ID: 34101053
[TBL] [Abstract][Full Text] [Related]
7. The Role of Immune Cells in Breast Tissue and Immunotherapy for the Treatment of Breast Cancer.
Goff SL; Danforth DN
Clin Breast Cancer; 2021 Feb; 21(1):e63-e73. PubMed ID: 32893093
[TBL] [Abstract][Full Text] [Related]
8. Machine Learning in oncology: A clinical appraisal.
Cuocolo R; Caruso M; Perillo T; Ugga L; Petretta M
Cancer Lett; 2020 Jul; 481():55-62. PubMed ID: 32251707
[TBL] [Abstract][Full Text] [Related]
9. Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer.
Deepak KGK; Vempati R; Nagaraju GP; Dasari VR; S N; Rao DN; Malla RR
Pharmacol Res; 2020 Mar; 153():104683. PubMed ID: 32050092
[TBL] [Abstract][Full Text] [Related]
10. Myeloid immunosuppression and immune checkpoints in the tumor microenvironment.
Nakamura K; Smyth MJ
Cell Mol Immunol; 2020 Jan; 17(1):1-12. PubMed ID: 31611651
[TBL] [Abstract][Full Text] [Related]
11. Peroxisomes in Immune Response and Inflammation.
Di Cara F; Andreoletti P; Trompier D; Vejux A; Bülow MH; Sellin J; Lizard G; Cherkaoui-Malki M; Savary S
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31398943
[TBL] [Abstract][Full Text] [Related]
12. Inflammation and Cancer: Triggers, Mechanisms, and Consequences.
Greten FR; Grivennikov SI
Immunity; 2019 Jul; 51(1):27-41. PubMed ID: 31315034
[TBL] [Abstract][Full Text] [Related]
13. Inflammation and Inflammatory Cytokine Contribute to the Initiation and Development of Ulcerative Colitis and Its Associated Cancer.
Yao D; Dong M; Dai C; Wu S
Inflamm Bowel Dis; 2019 Sep; 25(10):1595-1602. PubMed ID: 31287863
[TBL] [Abstract][Full Text] [Related]
14. Targeting Treg cells in cancer immunotherapy.
Tanaka A; Sakaguchi S
Eur J Immunol; 2019 Aug; 49(8):1140-1146. PubMed ID: 31257581
[TBL] [Abstract][Full Text] [Related]
15. Maftools: efficient and comprehensive analysis of somatic variants in cancer.
Mayakonda A; Lin DC; Assenov Y; Plass C; Koeffler HP
Genome Res; 2018 Nov; 28(11):1747-1756. PubMed ID: 30341162
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy in triple-negative breast cancer: Current situation and upcoming strategies.
He MY; Rancoule C; Rehailia-Blanchard A; Espenel S; Trone JC; Bernichon E; Guillaume E; Vallard A; Magné N
Crit Rev Oncol Hematol; 2018 Nov; 131():96-101. PubMed ID: 30293712
[TBL] [Abstract][Full Text] [Related]
17. When worlds collide: Th17 and Treg cells in cancer and autoimmunity.
Knochelmann HM; Dwyer CJ; Bailey SR; Amaya SM; Elston DM; Mazza-McCrann JM; Paulos CM
Cell Mol Immunol; 2018 May; 15(5):458-469. PubMed ID: 29563615
[TBL] [Abstract][Full Text] [Related]
18. Differences in breast cancer incidence among young women aged 20-49 years by stage and tumor characteristics, age, race, and ethnicity, 2004-2013.
Shoemaker ML; White MC; Wu M; Weir HK; Romieu I
Breast Cancer Res Treat; 2018 Jun; 169(3):595-606. PubMed ID: 29445940
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
